1. Tayebi Z, Saderi H, Gholami M, Houri H, Samie S, Boroumandi Sh. Evaluation of antimicrobial susceptibility of Streptococcus agalactiae isolates from patients with urinary tract infection (UTI) symptoms. Infect Epidemiol Med. 2016; 2 (4): 17-9. [
DOI:10.18869/modares.iem.2.4.17]
2. Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T, et al. Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016. JAMA Intern Med. 2019; 179 (4): 479-88. [
DOI:10.1001/jamainternmed.2018.7269]
3. Sendi P, Johansson L, Norrby-Teglund A. Invasive group B Streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections. Infection. 2008; 36 (2): 100-11. [
DOI:10.1007/s15010-007-7251-0]
4. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013; 31 Suppl 4: D20-6. [
DOI:10.1016/j.vaccine.2012.11.056]
5. Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017; 65 (suppl_2): S160-S172. [
DOI:10.1093/cid/cix656]
6. Girgitzova B, Minkov N, Zozikov B. Streptococcus agalactiae as a Urinary Tract Pathogen in Males and Non-pregnant Females. Int Urol Nephrol. 1991; 23 (4): 365-9. [
DOI:10.1007/BF02549609]
7. Muñoz P, Coque T, Rodríguez Créixems M, Bernaldo de Quirós JC, Moreno S, Bouza E. Group B Streptococcus: A Cause of Urinary Tract Infection in Nonpregnant Adults. Clin Infect Dis. 1992; 14 (2): 492-96. [
DOI:10.1093/clinids/14.2.492]
8. Ulett KB, Benjamin WH Jr, Zhuo F, Xiao M, Kong F, Gilbert GL, et al. Diversity of group B Streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol. 2009; 47(7): 2055-60. [
DOI:10.1128/JCM.00154-09]
9. Aungst M, King J, Steele A, Gordon M. Low colony counts of asymptomatic group B Streptococcus bacteriuria: a survey of practice patterns. Am J Perinatol. 2004; 21(7): 403-7. [
DOI:10.1055/s-2004-835310]
10. Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother. 2004; 38(10): 1692-701. [
DOI:10.1345/aph.1D630]
11. Graham JC, Galloway A. ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection. J Clin Pathol. 2001; 54 (12): 911-9. [
DOI:10.1136/jcp.54.12.911]
12. Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; 28th informational supplement. CLSI M100. CLSI, Wayne, PA. 2018.
13. Swain B, Rakshit A, Sahu KK, Sahoo N, Otta S. Group B Streptococcus: An Unusual Cause for Urinary Tract Infection. J Clin Diagn Res. 2017; 11 (8): DL05-DL06. [
DOI:10.7860/JCDR/2017/26025.10449]
14. Persson KM, Grabe M, Kristiansen P and Forsgren A. Significance of Group B Streptococci in Urine Cultures from Males and Non-pregnant Females. Scand J Infect Dis. 1988; 20 (1): 47-53. [
DOI:10.3109/00365548809117216]
15. Sewaify M, Nair S, Warsame S, Murad M, Alhubail A, Behbehani K, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait. J Diabetes Res. 2015; 2016: 1-6. [
DOI:10.1155/2016/6573215]
16. Yanai H, Hamasaki H, Tsuda N, Adachi H, Yoshikawa N, Moriyama S, et al. Group B streptococcus infection and diabetes: a review. J Microbiol Antimicrob. 2012; 4 (1): 1-5. [
DOI:10.5897/JMA11.088]
17. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990-2007. Clin Infect Dis. 2009; 49 (1): 85-92. [
DOI:10.1086/599369]
18. Hakeem LM, Bhattacharyya DN, Lafong C, Janjua KS, Serhan JT, Campbell IW. Diversity and complexity of urinary tract infection in diabetes mellitus. Br J Diabetes Vasc Dis. 2009; 9 (3): 119-25. [
DOI:10.1177/1474651409105654]
19. de Lastours V, Foxman, B. Urinary Tract Infection in Diabetes: Epidemiologic Considerations. Curr Infect Dis Rep. 2014; 16 (1): 389. [
DOI:10.1007/s11908-013-0389-2]
20. Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004; 42 (3): 1263-4. [
DOI:10.1128/JCM.42.3.1263-1264.2004]
21. Lopardo HA, Vidal P, Jeric P, Centron D, Paganini H, Facklam RR, et al. Argentinian Streptococcus Study Group. J Clin Microbiol. 2003; 41 (10): 4688-94. [
DOI:10.1128/JCM.41.10.4688-4694.2003]
22. Quiroga, M, Pegels E, Oviedo P, Pereyra E, Vergara, M. Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina. Braz. J Microbiol. 2008; 39 (2): 245-50. [
DOI:10.1590/S1517-83822008000200009]
23. Traub WH, Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy. 1997; 43 (1): 10-20. [
DOI:10.1159/000239529]
24. Jannati E, Roshani M, Arzanlou M, Habibzadeh S, Rahimi G, Shapuri R. Capsular serotype and antibiotic resistance of Group B Streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol. 2012; 4 (3): 130-5.
25. Rahbar M, Hajia M, Mohammadzadeh M. Urinary Tract Infections caused by Group B Streptococcus in adult women: Survey of 11800 urine culture results. Iran J Pathol. 2012; 7 (1): 32-7.